These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6977876)

  • 1. C-peptide response to glucagon in black and Indian insulin-dependent diabetics.
    Omar MA; Asmal AC
    S Afr Med J; 1982 Mar; 61(11):395-7. PubMed ID: 6977876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".
    Banerji MA
    J Pediatr Endocrinol Metab; 2002 Apr; 15 Suppl 1():493-501. PubMed ID: 12017222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide response to a glucose load in young blacks and Indians with insulin-dependent diabetes mellitus.
    Omar MA; Asmal AC
    S Afr Med J; 1984 Feb; 65(5):155-7. PubMed ID: 6695271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-cell response to intravenous glucagon in African-American and Hispanic children with type 2 diabetes mellitus.
    Taha DR; Castells S; Umpaichitra V; Bastian W; Banerji MA
    J Pediatr Endocrinol Metab; 2002 Jan; 15(1):59-67. PubMed ID: 11822582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-peptide response to glucagon in young diabetics.
    Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glucagon on net splanchnic cyclic AMP production in normal and diabetic men.
    Liljenquist JE; Bomboy JD; Lewis SB; Sinclair-Smith BC; Felts PW; Lacy WW; Crofford OB; Liddle GW
    J Clin Invest; 1974 Jan; 53(1):198-204. PubMed ID: 4357612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin-dependent diabetes mellitus.
    Park SW; Ihm SH; Yoo HJ; Park JY; Lee KU
    Diabetes Res Clin Pract; 1997 Sep; 37(3):165-71. PubMed ID: 9306037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
    Hendriksen C; Faber OK; Drejer J; Binder C
    Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal and postglucagon C-peptide levels in Ethiopians with diabetes.
    Siraj ES; Reddy SS; Scherbaum WA; Abdulkadir J; Hammel JP; Faiman C
    Diabetes Care; 2002 Mar; 25(3):453-7. PubMed ID: 11874929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of type I from insulin-treated type II diabetic patients by C-peptide measurement.
    Cravarezza P; Radaeli E; Toffoli C; Rigosa C
    Acta Diabetol Lat; 1986; 23(4):345-50. PubMed ID: 3564834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus.
    Madsbad S; Krarup T; McNair P; Christiansen C; Faber OK; Transbøl I; Binder C
    Acta Med Scand; 1981; 210(3):153-6. PubMed ID: 7027749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-dependent diabetes mellitus with early onset in blacks and Indians.
    Asmal AC; Jialal I; Leary WP; Makhoba P; Omar MA; Pillay NL; Thandroyen FT
    S Afr Med J; 1981 Jul; 60(3):91-3. PubMed ID: 7256449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum C-peptide concentrations and their value in evaluating the usefulness of insulin therapy in elderly diabetics.
    Kyllästinen M; Elfving S
    Gerontology; 1986; 32(6):317-26. PubMed ID: 3556328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic analysis of the response of plasma glucose, insulin, and C-peptide to glucagon injection in normal and diabetic subjects.
    Turco G; Brossa C; D'Alberto M; Regis G; Segre G; Bianchi E; Bruni B; Gamba S
    Diabetes; 1981 Aug; 30(8):685-93. PubMed ID: 7018972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.